Group One Trading’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $368K | Buy |
125,100
+85,900
| +219% | +$381K | ﹤0.01% | 3616 |
|
|
2025
Q4 | $195K | Sell |
39,200
-88,200
| -69% | -$385K | ﹤0.01% | 4387 |
|
|
2025
Q3 | $401K | Buy |
127,400
+126,500
| +14,056% | +$347K | ﹤0.01% | 3914 |
|
|
2025
Q2 | $2.03K | Buy |
+900
| New | +$2.56K | ﹤0.01% | 7409 |
|
|
2025
Q1 | – | Sell |
-503,800
| Closed | -$1.77M | – | 7486 |
|
|
2024
Q4 | $1.77M | Buy |
503,800
+353,800
| +236% | +$1.6M | ﹤0.01% | 2032 |
|
|
2024
Q3 | $711K | Sell |
150,000
-33,200
| -18% | -$152K | ﹤0.01% | 2588 |
|
|
2024
Q2 | $861K | Buy |
183,200
+114,900
| +168% | +$554K | ﹤0.01% | 2122 |
|
|
2024
Q1 | $310K | Buy |
+68,300
| New | +$303K | ﹤0.01% | 3189 |
|
|
2023
Q4 | – | Sell |
-21,100
| Closed | -$90.7K | – | 7286 |
|
|
2023
Q3 | $90.7K | Sell |
21,100
-78,600
| -79% | -$396K | ﹤0.01% | 4541 |
|
|
2023
Q2 | $517K | Sell |
99,700
-33,600
| -25% | -$236K | ﹤0.01% | 2981 |
|
|
2023
Q1 | $906K | Buy |
133,300
+100,600
| +308% | +$478K | ﹤0.01% | 2223 |
|
|
2022
Q4 | $80.8K | Sell |
32,700
-26,400
| -45% | -$67.7K | ﹤0.01% | 4622 |
|
|
2022
Q3 | $195K | Buy |
59,100
+45,100
| +322% | +$215K | ﹤0.01% | 4164 |
|
|
2022
Q2 | $68K | Buy |
14,000
+6,000
| +75% | +$40.7K | ﹤0.01% | 5305 |
|
|
2022
Q1 | $61K | Buy |
+8,000
| New | +$59.6K | ﹤0.01% | 5947 |
|
|
2017
Q4 | – | Sell |
-39
| Closed | -$16K | – | 4783 |
|
|
2017
Q3 | $16K | Buy |
39
+34
| +680% | +$24.4K | ﹤0.01% | 4144 |
|
|
2017
Q2 | $4K | Hold |
5
| – | – | ﹤0.01% | 4448 |
|
|
2017
Q1 | $5K | Buy |
+5
| New | +$6.07K | ﹤0.01% | 4268 |
|
|
2016
Q4 | – | Sell |
-3
| Closed | -$4K | – | 4376 |
|
|
2016
Q3 | $4K | Hold |
3
| – | – | ﹤0.01% | 4248 |
|
|
2016
Q2 | $7K | Buy |
3
+2
| +200% | +$4.18K | ﹤0.01% | 4173 |
|
|
2016
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 4359 |
|
|
2015
Q4 | $3K | Sell |
1
-11
| -92% | -$46.5K | ﹤0.01% | 4458 |
|
|
2015
Q3 | $57K | Buy |
12
+9
| +300% | +$54.2K | ﹤0.01% | 3438 |
|
|
2015
Q2 | $13K | Buy |
+3
| New | +$14.9K | ﹤0.01% | 4202 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 4625 |
|
|
2014
Q4 | – | Sell |
-2
| Closed | -$9.78K | – | 4672 |
|
|
2014
Q3 | $14K | Sell |
2
-5
| -71% | -$34.7K | ﹤0.01% | 4291 |
|
|
2014
Q2 | $60K | Sell |
7
-8
| -53% | -$98.3K | ﹤0.01% | 3405 |
|
|
2014
Q1 | $395K | Buy |
15
+10
| +200% | +$246K | 0.01% | 1829 |
|
|
2013
Q4 | $83K | Buy |
+5
| New | +$87.7K | ﹤0.01% | 3202 |
|
|
2013
Q3 | – | Sell |
-1
| Closed | -$16K | – | 5103 |
|
|
2013
Q2 | $16K | Buy |
+1
| New | +$22.4K | ﹤0.01% | 4192 |
|
Other funds holding ACHV
PBM
VCM
SAM
NCM
Group One Trading's ACHV Position: Q4 2025 in Review
Group One Trading sold out of Achieve Life Sciences (ACHV) in Q4 2025, closing a stake of 8,796 shares — an estimated $38.3K sold.
Group One Trading first reported a position in ACHV in Q2 2013 and held it in 26 quarters. The position peaked at $933K in Q1 2023. 77 funds tracked by Wall St. Rank hold ACHV as of Q4 2025.
- Group One Trading reported no remaining Achieve Life Sciences position as of Q4 2025 after selling out during the quarter.
- Group One Trading sold 8,796 Achieve Life Sciences shares in Q4 2025, an estimated $38.3K.
- Group One Trading first reported a position in Achieve Life Sciences in Q2 2013 and held it in 26 quarters.
- Group One Trading's Achieve Life Sciences position peaked at $933K in Q1 2023.
- 77 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2025.
Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.